Haleon plc
OTC: HLNCF0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Brian James McNamara
- Employees
- 24,561
- Headquarters
- Weybridge, United Kingdom
- IPO year
- 2022
- Market cap
- $39.3B
- Website
- https://www.haleon.com
Loading HLNCF…
Loading profile data…Frequently asked questions about HLNCF
What does Haleon plc (HLNCF) do?
Haleon plc operates as a global consumer healthcare enterprise, actively involved in the research, development, production, and distribution of a diverse range of products. Its business activities cover extensive regions, including North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers various sol...
Where does HLNCF trade?
Haleon plc (HLNCF) trades on the Other OTC.
What sector is HLNCF in?
Haleon plc (HLNCF) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Haleon plc?
Brian James McNamara is the chief executive officer of Haleon plc (HLNCF).
Where is Haleon plc headquartered?
Haleon plc is headquartered in United Kingdom.
Does HLNCF pay a dividend?
Yes — Haleon plc (HLNCF) paid a trailing twelve-month dividend of USD 0.10 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did HLNCF go public?
Haleon plc (HLNCF) completed its initial public offering in 2022.